scholarly journals Cyclin-Dependent Kinase 5 Differentially Regulates the Transcriptional Activity of the Glucocorticoid Receptor through Phosphorylation: Clinical Implications for the Nervous System Response to Glucocorticoids and Stress

2007 ◽  
Vol 21 (7) ◽  
pp. 1552-1568 ◽  
Author(s):  
Tomoshige Kino ◽  
Takamasa Ichijo ◽  
Niranjana D. Amin ◽  
Sashi Kesavapany ◽  
Yonghong Wang ◽  
...  

Abstract Glucocorticoids, major end effectors of the stress response, play an essential role in the homeostasis of the central nervous system and influence diverse functions of neuronal cells. We found that cyclin-dependent kinase 5 (CDK5), which plays important roles in the morphogenesis and functions of the nervous system and whose aberrant activation is associated with development of neurodegenerative disorders, interacted with the ligand-binding domain of the glucocorticoid receptor (GR) through its activator p35 or its active proteolytic fragment p25. CDK5 phosphorylated GR at multiple serines, including Ser203 and Ser211 of its N-terminal domain, and suppressed the transcriptional activity of this receptor on glucocorticoid-responsive promoters by attenuating attraction of transcriptional cofactors to DNA. In microarray analyses using rat cortical neuronal cells, the CDK5 inhibitor roscovitine differentially regulated the transcriptional activity of the GR on more than 90% of the endogenous glucocorticoid-responsive genes tested. Thus, CDK5 exerts some of its biological activities in neuronal cells through the GR, dynamically modulating GR transcriptional activity in a target promoter-dependent fashion.

Development ◽  
1993 ◽  
Vol 119 (4) ◽  
pp. 1029-1040 ◽  
Author(s):  
L.H. Tsai ◽  
T. Takahashi ◽  
V.S. Caviness ◽  
E. Harlow

Cyclin-dependent kinase 5 (cdk5) was originally isolated on the basis of its close primary sequence homology to the human cdc2 serine/threonine kinase, the prototype of the cyclin-dependent kinases. While kinase activities of both cdc2 and cdk2 are detected in proliferating cells and are essential for cells to progress through the key transition points of the cell cycle, cdk5 kinase activity has been observed only in lysates of adult brain. In this study, we compared the activity and expression of cdk5 with that of cdc2 and cdk2 in the embryonic mouse forebrain. The expression and activity of cdk5 increased progressively as increasing numbers of cells exited the proliferative cycle. In contrast, the expression and activity of cdc2 and cdk2 were maximum at gestational day 11 (E11) when the majority of cells were proliferating and fell to barely detectable levels at E17 at the end of the cytogenetic period. Immunohistochemical studies showed that cdk5 is expressed in postmitotic neurons but not in glial cells or mitotically active cells. Expression of cdk5 was concentrated in fasciculated axons of postmitotic neurons. In contrast to other cell division cycle kinases to which it is closely related, cdk5 appears not to be expressed in dividing cells in the developing brain. These observations suggest that cdk5 may have a role in neuronal differentiation but not in the cell division cycle in the embryonic nervous system.


Author(s):  
Helene Roumes ◽  
Julie Brossaud ◽  
Alois Lemelletier ◽  
Marie-Pierre Moisan ◽  
Veronique Pallet ◽  
...  

Open Biology ◽  
2020 ◽  
Vol 10 (1) ◽  
pp. 190287 ◽  
Author(s):  
Samanta Sharma ◽  
Piotr Sicinski

The cyclin-dependent kinase 5 (CDK5) represents an unusual member of the family of cyclin-dependent kinases, which is activated upon binding to non-cyclin p35 and p39 proteins. The role of CDK5 in the nervous system has been very well established. In addition, there is growing evidence that CDK5 is also active in non-neuronal tissues, where it has been postulated to affect a variety of functions such as the immune response, angiogenesis, myogenesis, melanogenesis and regulation of insulin levels. Moreover, high levels of CDK5 have been observed in different tumour types, and CDK5 was proposed to play various roles in the tumorigenic process. In this review, we discuss these various CDK5 functions in normal physiology and disease, and highlight the therapeutic potential of targeting CDK5.


2002 ◽  
Vol 71 (6) ◽  
pp. 2600-2606 ◽  
Author(s):  
Masahiko Terada ◽  
Hitoshi Yasuda ◽  
Syuro Kogawa ◽  
Kengo Maeda ◽  
Masakazu Haneda ◽  
...  

2017 ◽  
Vol 82 ◽  
pp. 96-104 ◽  
Author(s):  
Julie Brossaud ◽  
Hélène Roumes ◽  
Jean-Christophe Helbling ◽  
Marie-Pierre Moisan ◽  
Véronique Pallet ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document